Peptomyc has focused its project on the development of a new generation of cell-penetrating peptides (CPP) targeting the Myc oncoprotein, with the aim of treating different...
AurorA Science had led its first investment last December 2020, participating in the $13.8 million (€11.4 million) round from Spanish biotech Peptomyc. AurorA recently invested in...